JOSHUA BURGETT: Open Payments
NPI 1841378247 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208,941 in 392 payments from 6 companies in 2025. Trend: 2023 $1,496 · 2024 $23,201 · 2025 $208,941
Speaker / faculty: $150,332Travel & lodging: $38,857Consulting: $11,943Food & beverage: $7,808
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 215 | $130,135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 170 | $78,295 |
| Janssen Scientific Affairs, LLC | 2 | $196 |
| Alkermes, Inc. | 3 | $161 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, LYBALVI, UZEDY, ARISTADA.
Industry payments across CA — which companies pay providers there.
